Follow
Elie Ritch
Elie Ritch
University of British Columbia
Verified email at prostatecentre.com
Title
Cited by
Cited by
Year
Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer
G Vandekerkhove, WJ Struss, M Annala, HML Kallio, D Khalaf, ...
European urology 75 (4), 667-675, 2019
1662019
Circulating tumor DNA reveals clinically actionable somatic genome of metastatic bladder cancer
G Vandekerkhove, T Todenhöfer, M Annala, WJ Struss, A Wong, K Beja, ...
Clinical cancer research 23 (21), 6487-6497, 2017
1442017
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
G Vandekerkhove, JM Lavoie, M Annala, AJ Murtha, N Sundahl, S Walz, ...
Nature Communications 12 (1), 184, 2021
982021
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
C Herberts, M Annala, J Sipola, SWS Ng, XE Chen, A Nurminen, ...
Nature 608 (7921), 199-208, 2022
802022
Identification of hypermutation and defective mismatch repair in ctDNA from metastatic prostate cancer
E Ritch, SYF Fu, C Herberts, G Wang, EW Warner, E Schönlau, ...
Clinical Cancer Research 26 (5), 1114-1125, 2020
642020
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression
E Warner, C Herberts, S Fu, S Yip, A Wong, G Wang, E Ritch, AJ Murtha, ...
Clinical Cancer Research 27 (6), 1650-1662, 2021
632021
Activating AKT1 and PIK3CA mutations in metastatic castration-resistant prostate cancer
C Herberts, AJ Murtha, S Fu, G Wang, E Schönlau, H Xue, D Lin, ...
European urology 78 (6), 834-844, 2020
632020
Biallelic tumour suppressor loss and DNA repair defects in de novo small‐cell prostate carcinoma
ECP Chedgy, G Vandekerkhove, C Herberts, M Annala, AJ Donoghue, ...
The Journal of pathology 246 (2), 244-253, 2018
422018
Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA
E Ritch, AW Wyatt
Urologic Oncology: Seminars and Original Investigations 36 (8), 380-384, 2018
162018
Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy
JVW Bacon, DC Müller, E Ritch, M Annala, SG Dugas, C Herberts, ...
European Urology Oncology 5 (6), 677-686, 2022
82022
Genomic features of lung-recurrent hormone-sensitive prostate cancer
NM Fonseca, K Van der Eecken, C Herberts, S Verbeke, SWS Ng, ...
JCO precision oncology 6, e2100543, 2022
82022
Enhancing knowledge discovery from cancer genomics data with Galaxy
MA Albuquerque, BM Grande, EJ Ritch, P Pararajalingam, S Jessa, ...
Giga Science 6 (5), gix015, 2017
52017
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
EW Warner, K Van der Eecken, AJ Murtha, EM Kwan, C Herberts, J Sipola, ...
Nature Cancer, 1-17, 2024
42024
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes
EJ Ritch, C Herberts, EW Warner, SWS Ng, EM Kwan, JVW Bacon, ...
NPJ Precision Oncology 7 (1), 27, 2023
42023
Genome-wide CRISPR screen reveals SLFN11 as a potent mediator of cisplatin sensitivity in muscle-invasive bladder cancer
G Kumar, E Ritch, HZ Oo, CK Wang, D Tortora, D Thaper, I Moskalev, ...
Urologic Oncology: Seminars and Original Investigations 38 (12), 905, 2020
22020
A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer
D Tortora, ME Roberts, G Kumar, SS Kotapalli, E Ritch, JM Scurll, ...
Iscience 26 (5), 2023
12023
Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer
E Warner, K Van der Eecken, AJ Murtha, EM Kwan, SW Ng, XE Chen, ...
Cancer Research 82 (12_Supplement), 41-41, 2022
12022
Early Identification of Refractory/Relapsed Diffuse Large B Cell Lymphoma with Serial Ctdna Sampling
RN Rys, E Ritch, C Rushton, A Ahmed, E Brailovski, C Steidl, DW Scott, ...
Blood 142, 2996, 2023
2023
Abstract IA006: Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer
AW Wyatt, AJ Murtha, E Warner, K Van der Eecken, EM Kwan, C Herberts, ...
Cancer Research 83 (11_Supplement), IA006-IA006, 2023
2023
Clonal architecture and evolution of treatment-resistant prostate cancer via deep whole-genome ctDNA sequencing
C Herberts, M Annala, J Sipola, SW Ng, XE Chen, A Nurminen, ...
Cancer Research 82 (12_Supplement), 3625-3625, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20